TMCnet News
Eidos Therapeutics to Present at Two Upcoming Investor ConferencesSAN FRANCISCO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced that management will present a company overview at two upcoming investor conferences.
About Eidos Therapeutics Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). For more information, please visit www.eidostx.com. Media Contact: Carolyn Hawley, Canale Communications, (619) 849-5382, [email protected] For Investors Alex Gray, Burns McClellan, (212) 213-0006, [email protected] |